ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SEER Seer Inc

1.6801
-0.0399 (-2.32%)
19 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Seer Inc NASDAQ:SEER NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0399 -2.32% 1.6801 1.68 1.72 1.74 1.67 1.71 370,291 00:14:56

Seer to Participate in the TD Cowen 44th Annual Health Care Conference

21/02/2024 9:05pm

GlobeNewswire Inc.


Seer (NASDAQ:SEER)
Historical Stock Chart


From Dec 2023 to Jun 2024

Click Here for more Seer Charts.

Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, MA.

Seer’s management is scheduled to participate in a fireside chat and Q&A session on Monday, March 4th at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.

About SeerSeer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact:Carrie Mendivilinvestor@seer.bio

Media Inquiries: Patrick Schmidtpr@seer.bio

1 Year Seer Chart

1 Year Seer Chart

1 Month Seer Chart

1 Month Seer Chart